Kerry Holford

Stock Analyst at Berenberg Bank

(3.95)
# 1,847
Out of 5,073 analysts
204
Total ratings
57.4%
Success rate
8.5%
Average return

Stocks Rated by Kerry Holford

Eli Lilly and Company
Oct 21, 2026
Maintained: Buy
Price Target: $1,400
Current: $1,283.66
Upside: +9.06%
GSK plc
Oct 14, 2026
Reiterated: Buy
Price Target: 2,200p
Current: 1,869p
Upside: +17.74%
Novo Nordisk
Oct 13, 2026
Reiterated: Hold
Price Target: $47
Current: $39.35
Upside: +19.44%
Pfizer
Oct 7, 2026
Reiterated: Hold
Price Target: $25
Current: $30.11
Upside: -16.97%
Novartis AG
Oct 5, 2026
Reiterated: Hold
Price Target: CHF 105.00
Current: CHF 126.50
Upside: -17.00%
Novartis AG
Jul 27, 2026
Reiterated: Hold
Price Target: $141 → $147
Current: $153.64
Upside: -4.32%
GSK plc
Nov 25, 2025
Reiterated: Hold
Price Target: $41 → $43
Current: $50.63
Upside: -15.07%
Sanofi
May 16, 2025
Reiterated: Buy
Price Target: €105.00 → €120.00
Current: €73.58
Upside: n/a
Eagle Football Group SA
Apr 1, 2025
Reiterated: Hold
Price Target: €1.60
Current: €1.62
Upside: n/a
The Estée Lauder Companies
Mar 24, 2025
Reiterated: Hold
Price Target: $65 → $60
Current: $106.12
Upside: n/a
Reiterated: Buy
Price Target: 100p
Current: 36p
Upside: n/a
Reiterated: Hold
Price Target: €150.00
Current: €146.40
Upside: n/a